Author details

Full Name

Ivelin S Georgiev

Affiliation

ORCID

Career Start Year

2006

Papers

117

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36708513	Functional HIV-1/HCV cross-reactive antibodies isolated from a chronically co-infected donor.	Cell Rep	2023
38085509	Development of LIBRA-seq for the guinea pig model system as a tool for the evaluation of antibody responses to multivalent HIV-1 vaccines.		2023
37399208	Adaptation of a transmitted/founder simian-human immunodeficiency virus for enhanced replication in rhesus macaques.		2023
35241839	Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking.	Nat Biotechnol	2022
35710908	Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine.	Nat Commun	2022
35472136	An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer.	J Clin Invest	2022
35401559	High-Throughput B Cell Epitope Determination by Next-Generation Sequencing.	Front Immunol	2022
36516766	Neutralization fingerprinting technology for characterizing polyclonal antibody responses to dengue vaccines.	Cell Rep	2022
34984325	Sequence and functional characterization of a public HIV-specific antibody clonotype.	iScience	2022
34592170	Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition.	Cell Rep	2021
34056628	Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions.	Cell Rep Med	2021
34100018	Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking.	bioRxiv	2021
33662277	B cell engagement with HIV-1 founder virus envelope predicts development of broadly neutralizing antibodies.		2021
33651828	Correction: RV144 HIV-1 vaccination impacts post-infection antibody responses.	PLoS Pathogens	2021
34341788	Single-Cell Profiling of the Antigen-Specific Response to BNT162b2 SARS-CoV-2 RNA Vaccine.	bioRxiv	2021
34579201	Simultaneous Immunization with Multiple Diverse Immunogens Alters Development of Antigen-Specific Antibody-Mediated Immunity.	Vaccines	2021
34372503	Elicitation of Neutralizing Antibody Responses to HIV-1 Immunization with Nanoparticle Vaccine Platforms.	Viruses	2021
35003053	Polyclonal Broadly Neutralizing Antibody Activity Characterized by CD4 Binding Site and V3-Glycan Antibodies in a Subset of HIV-1 Virus Controllers.	Frontiers in Immunology	2021
33398266	Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functions.	bioRxiv	2020
31913636	Spontaneous Glycan Reattachment Following N-Glycanase Treatment of Influenza and HIV Vaccine Antigens.	J Proteome Res	2020
32015557	Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor.	Nat Med	2020
31581292	Longitudinal Antibody Responses in People Who Inject Drugs Infected With Similar Human Immunodeficiency Virus Strains.	J Infect Dis	2020
32275203	Envelope characteristics in individuals who developed neutralizing antibodies targeting different epitopes in HIV-1 subtype C infection.	Virology	2020
33290394	RV144 HIV-1 vaccination impacts post-infection antibody responses.	PLoS Pathogens	2020
32620559	Human antibodies neutralize enterovirus D68 and protect against infection and paralytic disease.	Sci Immunol	2020
30933973	Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence features.	PLoS Computational Biology	2019
31787378	High-Throughput Mapping of B Cell Receptor Sequences to Antigen Specificity.	Cell	2019
31893251	Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion Glycoprotein From Respiratory Syncytial Virus Subtype B.	Pathogens and Immunity	2019
30876875	Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual.	Immunity	2019
30980067	Author Correction: Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses.	Nature Immunology	2019
30838378	NFPws: a web server for delineating broadly neutralizing antibody specificities from serum HIV-1 neutralization data.		2019
29548671	A Neutralizing Antibody Recognizing Primarily N-Linked Glycan Targets the Silent Face of the HIV Envelope.	Immunity	2018
29040163	Adipose Tissue is Enriched for Activated and Late-Differentiated CD8+ T Cells and Shows Distinct CD8+ Receptor Usage, Compared With Blood in HIV-Infected Persons.	Journal of acquired immune deficiency syndromes (1999)	2018
30403372	Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core.	Elife	2018
29867235	Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1.	Nat Med	2018
29861170	Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection.	Cell Host Microbe	2018
29451984	Two-Component Ferritin Nanoparticles for Multimerization of Diverse Trimeric Antigens.	ACS Infect Dis	2018
29444432	Surface-Matrix Screening Identifies Semi-specific Interactions that Improve Potency of a Near Pan-reactive HIV-1-Neutralizing Antibody.	Cell Rep	2018
29558468	Characterization of broadly neutralizing antibody responses to HIV-1 in a cohort of long term non-progressors.	PLoS ONE	2018
28275193	Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity.	Journal of Virology	2017
28445724	Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation.	Cell Rep	2017
28878010	Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge.	Science Translational Medicine	2017
28783671	Potent and broad HIV-neutralizing antibodies in memory B cells and plasma.	Science immunology	2017
28358804	A critical analysis of computational protein design with sparse residue interaction graphs.	PLoS Computational Biology	2017
28739897	Antibacterial photosensitization through activation of coproporphyrinogen oxidase.	Proc Natl Acad Sci U S A	2017
28514685	Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding Loop.	Immunity	2017
29212041	Soluble Prefusion Closed DS-SOSIP.664-Env Trimers of Diverse HIV-1 Strains.	Cell Reports	2017
29281818	Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models.	Cell Reports	2017
28298421	Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide.	Science Translational Medicine	2017
28052137	Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting.	PLoS Pathog	2017